Datametrix
  • Datametrex (DM) has received a purchase order from a Canadian mining company for COVID-19 test kits
  • Datametrex has generated approximately $2.8 million in test kit sales to Canadian mining companies
  • Datametrex is a Canadian-based cybersecurity company focusing on collecting and presenting structured and unstructured data using AI and ML
  • Datametrex AI Limited (DM) opened at C$0.15 per share

Datametrex AI (DM) has received a purchase order from a Canadian mining company for COVID-19 test kits.

The total amount of the sale is approximately C$250,000. To date, Datametrex has generated approximately $2.8 million in test kit sales to Canadian mining companies.

Under the terms of the sale, Datametrex will provide 1drop COVID-19 qPCR Detection Kits, a PCR machine, an RNA extraction machine, and RNA extraction kits.

Datametrex anticipates little or no upfront costs associated with the sale of the test kits. All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites.

“This further confirms Datametrex’s approach with its diverse COVID-19 product portfolio of health security products and services,” stated Marshall Gunter, CEO of Datametrex.

Datametrex’s mission is to provide tools that support companies in fulfilling their operational goals, including Health and Safety, with predictive and preventive technologies.

Datametrex AI Limited (DM) opened at C$0.15 per share.

More From The Market Online

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.

WELL Health and Microsoft to future-proof North American healthcare

WELL Health Technologies (TSX:WELL) and Microsoft (NDAQ:MSFT) sign a five-year deal to expedite healthcare's transition into the digital age.

Sona Nanotech reveals results from breast cancer study

Sona Nanotech (CSE:SONA) reveals additional results from the triple-negative breast cancer murine model portion of its research study.